Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02678416 · ClinicalTrials.gov registry record · Phase 4
Reduction in Pain Intensity Following IV or Oral Pain-relieving Products
A Phase 4 study, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
NCT02678416 is a Phase 4 study that has completed, run by Mallinckrodt. The registered enrollment target is 79 participants.
The verdict
NCT02678416, a Phase 4 study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate two experimental pain models to see if they would be useful for comparing different products for reduction in pain intensity. The models evaluated were the ultraviolet-B (UVB) burn and intradermal capsaicin experimental pain models. Medications compared were a single dose each, of intravenous (IV) acetaminophen, oral acetaminophen, placebo, and IV morphine.
Interventions
- DRUG IV Acetaminophen (Treatment A)
- DRUG Oral Acetaminophen (Treatment B)
- DRUG Placebo (Treatment C)
- OTHER Morphine (Treatment D)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2015-12-07 |
| Est. Completion | 2016-06-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02678416
The ClinicalTrials.gov registry entry for NCT02678416 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which IV Acetaminophen (Treatment A) is the first listed.
NCT02678416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02678416 about?
NCT02678416 is a clinical study titled "Reduction in Pain Intensity Following IV or Oral Pain-relieving Products". The purpose of this study is to evaluate two experimental pain models to see if they would be useful for comparing different products for reduction in pain intensity. The models evaluated were the ultraviolet-B (UVB) burn and intradermal capsaicin experimental pain models. Medications compared were...
What is the current status of trial NCT02678416?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2015-12-07. Estimated completion is 2016-06-13.
What interventions are being tested in trial NCT02678416?
The interventions under investigation include: IV Acetaminophen (Treatment A) (DRUG), Oral Acetaminophen (Treatment B) (DRUG), Placebo (Treatment C) (DRUG), Morphine (Treatment D) (OTHER).
Who is sponsoring clinical trial NCT02678416?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.